Apart from its ability to inhibit to angiogenesis, we also found that PEDF suppressed RET expression in endocrine-resistant breast cancer cells and that this suppression was associated with the reversal of tamoxifen resistance. The gene discussed is SERPINF1; the disease is breast carcinoma.